Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(8%)

Phase Distribution

Ph phase_3
1
8%
Ph phase_2
1
8%
Ph phase_4
8
67%
Ph early_phase_1
1
8%
Ph not_applicable
1
8%

Phase Distribution

1

Early Stage

1

Mid Stage

9

Late Stage

Phase Distribution12 total trials
Early Phase 1First-in-human
1(8.3%)
Phase 2Efficacy & side effects
1(8.3%)
Phase 3Large-scale testing
1(8.3%)
Phase 4Post-market surveillance
8(66.7%)
N/ANon-phased studies
1(8.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

12

all time

Status Distribution
Completed(6)
Terminated(1)
Other(5)

Detailed Status

Completed6
unknown5
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
0
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (8.3%)
Phase 21 (8.3%)
Phase 31 (8.3%)
Phase 48 (66.7%)
N/A1 (8.3%)

Trials by Status

completed650%
unknown542%
terminated18%

Recent Activity

0 active trials
Showing 5 of 12
completedphase_4

Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology During IVF/ICSI

NCT04724486
completedphase_4

Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes.

NCT04724343
completedphase_4

Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSI

NCT04727684
completedphase_4

Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients.

NCT04727671
unknownphase_2

Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer

NCT05212857
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT04724486Phase 4

Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology During IVF/ICSI

Completed
NCT04724343Phase 4

Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes.

Completed
NCT04727684Phase 4

Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSI

Completed
NCT04727671Phase 4

Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients.

Completed
NCT05212857Phase 2

Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer

Unknown
NCT05151016Early Phase 1

Long-term Use of Mifepristone in the Treatment of Adenomyosis

Unknown
NCT03809221Phase 4

The Effectiveness and Safety of the Prolonged Down-regulation Protocol for Controlled Ovarian Hyperstimulation

Unknown
NCT02715232Phase 4

Effects of Sex Steroids on the Serotonin System

Unknown
NCT02825290Phase 4

Modified Luteal Support for Frozen-Thawed Embryo Transfer - A Prospective Study

Unknown
NCT01581359Phase 4

The Effect of Pre-treatment With GnRH Analogues Prior in Vitro Fertilization in Patients With Endometriosis

Completed
NCT01007851Phase 3

Single Dose Gonadotropin-releasing Hormone (GnRH) Agonist Administration in the Luteal Phase of GnRH Antagonist Stimulated ICSI-ET Cycles

Terminated
NCT00516490Not Applicable

GnRH Agonist Administration in the Luteal Phase of ICSI-ET Cycles

Completed

All 12 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
12